Health and Fitness Health and Fitness
Fri, December 3, 2010
[ Fri, Dec 03rd 2010 ] - Market Wire
Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 9, 2010
Thu, December 2, 2010
[ Thu, Dec 02nd 2010 ] - Market Wire
Roto-Rooter Acquires Kansas City Franchise
[ Thu, Dec 02nd 2010 ] - Market Wire
Ron Lombardi Named CFO for Prestige Brands Holdings, Inc.
[ Thu, Dec 02nd 2010 ] - Market Wire
Insight Imaging Announces Consensual Restructuring Agreement with Majority Note Holders
[ Thu, Dec 02nd 2010 ] - Market Wire
Healthways Announces Planned Retirement of Chief Financial Officer, Mary Chaput
[ Thu, Dec 02nd 2010 ] - Market Wire
Aetna si aggiudica il premio "International Benefits Provider of the Year"
[ Thu, Dec 02nd 2010 ] - Market Wire
la?occasion de la 14me r©union annuelle de la No .. ociety, St. Jude Medical annonce de nouvelles app
[ Thu, Dec 02nd 2010 ] - Market Wire
First Patient Enrolled in AtriCurea?s DEEP AF Feasibility Trial
[ Thu, Dec 02nd 2010 ] - Market Wire
MedPro Safety Products Receives FDA Market Cleara .. ce for Passive Safety Winged Blood Collection Set
[ Thu, Dec 02nd 2010 ] - Market Wire
PlanClear Releases In-Depth Study on Positron; 2010 Progress and Strong Market Position Cited
[ Thu, Dec 02nd 2010 ] - Market Wire
Aetna wint onderscheiding aInternational Benefits Provider of the Yeara
[ Thu, Dec 02nd 2010 ] - Market Wire
Alnylama?s Tuschl II Patent Fully Upheld in European Opposition Proceedings
[ Thu, Dec 02nd 2010 ] - Market Wire
St. Jude Medical kondigt tijdens de 14de jaarlijk .. merikaanse Vereniging voor Neuromodulatie de nieu
[ Thu, Dec 02nd 2010 ] - Market Wire
European Economic Analysis Shows Cost Benefit of .. ronization Therapy in Mild Heart Failure Patients
[ Thu, Dec 02nd 2010 ] - Market Wire
Aetna als aInternational Benefits Provider of the Yeara ausgezeichnet
[ Thu, Dec 02nd 2010 ] - Market Wire
Aetna est laur©ate du Prix Benefits Provider of .. ternational de prestations sociales de la?ann©e)
[ Thu, Dec 02nd 2010 ] - Market Wire
Teva Comments on Patent Infringement Lawsuit Filed by Momenta and Sandoz
[ Thu, Dec 02nd 2010 ] - Market Wire
St. Jude Medical gibt auf dem 14. jhrlichen Meeti .. odulation Society neue Zulassungen der fnfadrigen
[ Thu, Dec 02nd 2010 ] - Market Wire
Aetna Wins aInternational Benefits Provider of the Yeara Award
[ Thu, Dec 02nd 2010 ] - Market Wire
Minnesota Vikings' Linebacker E.J. Henderson Join .. SPO to Endorse New SPO Wellness(TM) Product Line
[ Thu, Dec 02nd 2010 ] - Market Wire
Commercialization Phase to Begin During Q1 2011
[ Thu, Dec 02nd 2010 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Announces Prelimi .. ng In Connection With Rex Medical L.P. Litigation
[ Thu, Dec 02nd 2010 ] - Market Wire
Humana Military Awarded Two Patient Appointing Services Contracts
[ Thu, Dec 02nd 2010 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Announces Agreeme .. s to Extend Certain Deadlines under Support Agree
[ Thu, Dec 02nd 2010 ] - Market Wire
Abiomed Receives Conditional FDA Approval for Stu .. ng Heart Muscle Damage Following PCI in STEMI Pat
[ Thu, Dec 02nd 2010 ] - Market Wire
New Clinical Data Evaluating AVEOa?s Tivozanib in .. to be Presented at 33rd Annual San Antonio Breast
[ Thu, Dec 02nd 2010 ] - Market Wire
Universal Health Care to Offer Healthways SilverSneakers to Medicare Advantage Members
[ Thu, Dec 02nd 2010 ] - Market Wire
Geron Initiates Randomized Phase 2 Clinical Trial of Imetelstat in Breast Cancer
[ Thu, Dec 02nd 2010 ] - Market Wire
Merck to Acquire SmartCells, Inc.
[ Thu, Dec 02nd 2010 ] - Market Wire
ShangPharma to Present at Two Investor Conferences in Hong Kong, December 6 a" 7, 2010

ShangPharma to Present at Two Investor Conferences in Hong Kong, December 6 a" 7, 2010


Published on 2010-12-02 11:20:27 - Market Wire
  Print publication without navigation


SHANGHAI--([ BUSINESS WIRE ])--ShangPharma Corporation (NYSE:SHP) (aShangPharmaa or the aCompanya), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that Kevin Chen, Chief Operating Officer and Chief Financial Officer of ShangPharma, will be presenting at two investor conferences in Hong Kong on December 6 and 7, 2010:

  • Citi
    Hong Kong/China Mini Conference 2010 (Theme: Healthcare)
    December 6 a" 7, 2010
  • Bank of America Merrill Lynch
    New China IPOs Corporate Day
    December 7, 2010

Presentation materials can be found under the aWebcast and Presentationa™ section of the Companya™s investor relations website: [ http://ir.shangpharma.com ].

About ShangPharma Corp.

ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit [ www.shangpharma.com ].

Contributing Sources